Exicure, Inc.
A biotechnology company developing nucleic acid therapeutics targeting ribonucleic acid. The company efficiently screens thousands of oligonucleotides to identify candidates in appropriate cell and live animal models. The company is developing therapeutics for non-opioid pain relief, Huntington's disease, Angelman syndrome, alopecia, and more. Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | Illinois |
Employees | 5 |
Founded | 2011 |
Financials | |
|---|---|
Market Capitalization | 2.86M |
Revenue | 0.50M |
Operating Income | -11.29M |
Operating Margin | -2258.60% |
Net Income | -13.34M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 3673 / 5373 |
Sector : Healthcare | 375 / 1144 |
Industry : Biotechnology | 119 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 5510 / 5565 |
Sector : Healthcare | 1148 / 1182 |
Industry : Biotechnology | 652 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3614 / 5436 |
Sector : Healthcare | 403 / 1164 |
Industry : Biotechnology | 148 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 5131 / 5330 |
Sector : Healthcare | 1115 / 1174 |
Industry : Biotechnology | 618 / 667 |